AstraZeneca, Britain’s largest listed company, is facing a crisis that could threaten the country’s life sciences industry. With over 300,000 jobs and a £108bn ($145bn) valuation, the sector is seen as a vital component of Britain’s economy. However, AstraZeneca’s problems may signal a broader decline in the industry.
Prime Minister Sir Keir Starmer has touted the life sciences sector as “rocket fuel” for the stagnant economy. But with AstraZeneca struggling, this promise may be at risk. The company’s falling out with Britain could have far-reaching consequences for the country’s reputation as a global leader in the field.
The impact of AstraZeneca’s crisis on Britain’s life sciences sector will be closely watched by policymakers and industry experts. As the country seeks to maintain its position as a major player in the global market, it remains to be seen whether the sector can recover from this setback.
Source: https://www.economist.com/britain/2025/08/03/astrazenecas-falling-out-with-britain